Pfizer wins preliminary injunction in Denmark against generic Lipitor version |
|
|
|
Published
:
Fri, 23 Feb 2007 14:34
|
LONDON (AFX) - Pfizer Inc said that a Danish court has granted a preliminary injunction against Nomeco A/S -- the largest pharmaceutical wholesaler in Denmark -- that prohibits the sale of a generic version of cholesterol-lowering drug Lipitor by generics manufacturer Ranbaxy.The injunction, which is subject to possible appeal by Nomeco, requires Ranbaxy's generic atorvastatin product to be withdrawn from the Danish market pending the outcome of a patent infringement trial that has not yet been scheduled.At issue are three Pfizer patents covering atorvastatin calcium, the active ingredient in Lipitor, as well as processes and intermediate compounds used to make atorvastatin. The latest-expiring of the patents provides coverage for Lipitor through November, 2011.The court ruled in Pfizer's favor on all three patents.newsdesk@afxnews.comrwCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
|
|
|
|
Print this Story
Pfizer to appeal Canadian decision 